Analyst Ratings For ASGN Inc (NYSE:ASGN)
Today, Robert W. Baird reiterated its Hold rating on ASGN Inc (NYSE:ASGN).
There are 6 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on ASGN Inc (NYSE:ASGN) is Buy with a consensus target price of $79.8333 per share, a potential 13.52% downside.
Some recent analyst ratings include
- 7/26/2018-Robert W. Baird Reiterated Rating of Hold .
- 2/15/2018-William Blair Reiterated Rating of Outperform.
Recent Insider Trading Activity For ASGN Inc (NYSE:ASGN)
ASGN Inc (NYSE:ASGN) has insider ownership of 3.90% and institutional ownership of 83.42%.
- On 5/21/2018 Arshad Matin, Director, sold 2,000 with an average share price of $84.62 per share and the total transaction amounting to $169,240.00.
- On 5/14/2018 Peter T Dameris, CEO, sold 18,750 with an average share price of $82.44 per share and the total transaction amounting to $1,545,750.00.
- On 3/5/2018 Edwin A Sheridan, Director, sold 22,404 with an average share price of $77.64 per share and the total transaction amounting to $1,739,446.56.
- On 3/2/2018 Edwin A Sheridan, Director, sold 77,596 with an average share price of $77.79 per share and the total transaction amounting to $6,036,192.84.
- On 2/28/2018 Edwin A Sheridan, Director, sold 9,100 with an average share price of $78.38 per share and the total transaction amounting to $713,258.00.
- On 2/26/2018 Randolph C Blazer, Insider, sold 10,000 with an average share price of $78.73 per share and the total transaction amounting to $787,300.00.
- On 2/20/2018 Marty R Kittrell, Director, sold 2,000 with an average share price of $76.24 per share and the total transaction amounting to $152,480.00.
About ASGN Inc (NYSE:ASGN)
ASGN Incorporated provides IT and professional services in the technology, digital, creative, healthcare technology, engineering, life sciences, and government sectors in the United States, Europe, and Canada. The company's Apex segment offers technical, digital, and creative and scientific professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients; IT staffing and consulting services comprising IT infrastructure, application development, project management, and healthcare IT professionals; and creative, marketing, advertising, and digital professionals. It also provides scientific, engineering, and clinical research staffing and services for temporary and permanent assignments, such as chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled professionals. This segment serves companies from various industries, as well as advertising agencies and company marketing departments. Its Oxford segment recruits and delivers experienced IT, engineering, and regulatory and compliance consultants to clients for temporary assignments and project engagements; provides permanent placements in technology, engineering, sales, executive, financial, accounting, scientific, legal, and operations positions; and offers locally-based contract and permanent life science professionals to clients with research and development projects. The company's ECS segment delivers solutions in cloud, cybersecurity, software development, IT modernization, and science and engineering. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. The company was founded in 1985 and is headquartered in Calabasas, California.
Recent Trading Activity for ASGN Inc (NYSE:ASGN)
Shares of ASGN Inc closed the previous trading session at 92,31 up +5,55 6,40 % with 92.66 shares trading hands.
